Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies

被引:43
作者
Borras, Leo [1 ]
Gunde, Tea [1 ]
Tietz, Julia [1 ]
Bauer, Ulrich [1 ]
Hulmann-Cottier, Valerie [1 ]
Grimshaw, John P. A. [1 ]
Urech, David M. [1 ]
机构
[1] ESBATech, ALCON Biomed Res Unit, CH-8952 Schlieren, Switzerland
关键词
ANTI-P185HER2; ANTIBODY; POSTERIOR SEGMENT; PROTEIN STABILITY; V-H; PHAGE; IMPROVEMENT; REPERTOIRE; FRAMEWORKS; LIBRARIES; AFFINITY;
D O I
10.1074/jbc.M109.072876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite their favorable pharmacokinetic properties, single-chain Fv antibody fragments (scFvs) are not commonly used as therapeutics, mainly due to generally low stabilities and poor production yields. In this work, we describe the identification and optimization of a human scFv scaffold, termed FW1.4, which is suitable for humanization and stabilization of a broad variety of rabbit antibody variable domains. A motif consisting of five structurally relevant framework residues that are highly conserved in rabbit variable domains was introduced into FW1.4 to generate a generically applicable scFv scaffold, termed FW1.4gen. Grafting of complementarity determining regions (CDRs) from 15 different rabbit monoclonal antibodies onto FW1.4 and their derivatives resulted in humanized scFvs with binding affinities in the range from 4.7 x 10(-9) to 1.5 x 10(-11) M. Interestingly, minimalistic grafting of CDRs onto FW1.4gen, without any substitutions in the framework regions, resulted in affinities ranging from 5.7 x 10(-10) to < 1.8 x 10(-12) M. When compared with progenitor rabbit scFvs, affinities of most humanized scFvs were similar. Moreover, in contrast to progenitor scFvs, which were difficult to produce, biophysical properties of the humanized scFvs were significantly improved, as exemplified by generally good production yields in a generic refolding process and by apparent melting temperatures between 53 and 86 degrees C. Thus, minimalistic grafting of rabbit CDRs on the FW1.4gen scaffold presents a simple and reproducible approach to humanize and stabilize rabbit variable domains.
引用
收藏
页码:9054 / 9066
页数:13
相关论文
共 37 条
[1]  
Adair John R., 1994, Human Antibodies and Hybridomas, V5, P41
[2]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[3]   CANONICAL STRUCTURES FOR THE HYPERVARIABLE REGIONS OF IMMUNOGLOBULINS [J].
CHOTHIA, C ;
LESK, AM .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (04) :901-917
[4]   Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression [J].
Demarest, Stephen J. ;
Chen, Gang ;
Kimmel, Bruce E. ;
Gustafson, David ;
Wu, Jane ;
Salbato, Jared ;
Poland, John ;
Elia, Marikka ;
Tan, Xuqiu ;
Wong, Ken ;
Short, Jay ;
Hansen, Genevieve .
PROTEIN ENGINEERING DESIGN & SELECTION, 2006, 19 (07) :325-336
[5]  
der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215
[6]   X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM 3 VARIANTS OF HUMANIZED ANTI-P185HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING [J].
EIGENBROT, C ;
RANDAL, M ;
PRESTA, L ;
CARTER, P ;
KOSSIAKOFF, AA .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (04) :969-995
[7]   Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering [J].
Ewert, S ;
Honegger, A ;
Plückthun, A .
METHODS, 2004, 34 (02) :184-199
[8]   Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach [J].
Ewert, S ;
Honegger, A ;
Plückthun, A .
BIOCHEMISTRY, 2003, 42 (06) :1517-1528
[9]   Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition [J].
Fellouse, FA ;
Wiesmann, C ;
Sidhu, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12467-12472
[10]   Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the AVASTIN™ Fab [J].
Fuh, G ;
Wu, P ;
Liang, WC ;
Ultsch, M ;
Lee, CV ;
Moffat, B ;
Wiesmann, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) :6625-6631